肿瘤免疫学, 放射肿瘤学与临床试验国际研讨会

暨第三届三名工程学术会议暨第一届多中心临床试验设计培训

邀请函

尊敬的各位同道、专家：

       肿瘤免疫学, 放射肿瘤学与临床试验国际研讨会暨第三届三名工程学术会议暨第一届多中心临床试验设计培训将于2019年6月14日至15日在广东省深圳市香港大学深圳医院学术报告厅召开，大会专设委员会诚挚邀请您出席本次会议。

本次论坛由中美放射肿瘤学会(SANTRO)、中美血液肿瘤学会（CAHON）、香港大学深圳医院临床肿瘤中心、香港大学临床肿瘤学系、深圳市抗癌协会、深圳市医学会、深圳市医师学会及加拿大多伦多玛格莉特癌症中心联合举办，主旨为“肿瘤诊治最新进展与创新临床试验设计”。此次会议是深圳市卫生和计划生育委员会推出持续5年的三名工程项目内容之一，力争使深圳市肿瘤防治能力达到国内一流，国际知名的水平。

鉴于癌症研究与治疗的迅速发展，肿瘤免疫学, 放射肿瘤学与临床试验国际研讨会暨第三届三名工程学术会议暨第一届多中心临床试验设计培训应运而生。这将为引入国际知名专家探索的最新肿瘤研究发现至关重要，并将为高水平知识交流和未来进一步的合作提供平台。本次会议将围绕多学科免疫治疗、创新临床试验设计、数据分析、未来科研项目申请及文章发表等方面进行深入探讨。

大会组委会诚挚邀请您参会。我們诚挚感激您的参与及指导, 此次大会期待您的莅临。

此致

敬礼！

International Oncology Symposium on Advances in Immuno-Oncology, Radiation Oncology and Clinical Trials

cum the 3rd Sanming Project Conference cum the 1st Program on Multicenter Clinical Trials Design Training

Dear All,

I have the greatest pleasure in inviting you to attend the International Oncology Symposium on Advances in Immuno-Oncology, Radiation Oncology and Clinical Trials cum the 3rd Sanming Project Conference cum the 1st Program on Multicenter Clinical Trials Design Training, which will be held on 14-15 June, 2019 at The University of Hong Kong–Shenzhen Hospital in Shenzhen China.

This Symposium is jointly organized by Sino-American Network in Radiation Oncology (SANTRO), Chinese American Hematologist and Oncologist Network (CAHON), Clinical Oncology Center of The University of Hong Kong-Shenzhen Hospital, Department of Clinical Oncology of The University of Hong Kong, Shenzhen Anti-cancer Association, Shenzhen Medical Doctor Association, Shenzhen Medical Association and Radiation Oncology Center, Princess Margaret Cancer Center, Toronto, Canada with the theme of “Advances in Immuno-Oncology and Innovative Clinical Trials”. The Symposium is an important developmental milestone of the “Sanming Project of Medicine in Shenzhen” coordinated by Health and Family Planning Commission of Shenzhen Municipality, which will run for five years from 2017 to 2021, aimed to bolster Shenzhen as the city of excellence in cancer management in China and worldwide. In view of the rapid development of cancer research and treatment, an international oncology symposium will be of paramount importance for exploring the latest advances on cancer management from internationally renowned experts and providing an academic platform fostering knowledge exchange and future collaboration. The Symposium shall encompass a diversity of programmes ranging from training for clinical trials design to clinical research talents, immuno-oncology of multiple disciplines and specialties, data analysis, future grants application and publications.

We cordially look forward to seeing you in Shenzhen in June of 2019. Thank you very much for your support and acceptance of our invitation.

Should you have any questions, please do not hesitate to contact Ms. Carol Liu (Email: liumd@hku-szh.org; Tel: +86- 0755-86913333-2997).

Yours sincerely,